Parallax Volatility Advisers, L.P. Puma Biotechnology, Inc. Transaction History

Parallax Volatility Advisers, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $1,105 - $2,564	-176 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $25,155 - $41,525	-3,870 Reduced 95.65%	176 $2,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $35,402 - $51,991	4,046 New	4,046 $43,000
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $60,233 - $122,872	-2,900 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $591,623 - $1.38 Million	-29,478 Reduced 91.04%	2,900 $59,000
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $1.13 Million - $1.64 Million	-27,373 Reduced 45.81%	32,378 $1.49 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $2.89 Million - $4.08 Million	59,751 New	59,751 $3.53 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $260,769 - $433,524	-4,368 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $409,936 - $578,541	4,368	4,368 $432,000

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $136M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.